Julie A Johnson
Cited by
Cited by
Estimation of the Warfarin dose with clinical and pharmacogenetic data
JJA Klein TE, Altman RB, Eriksson N, Gage BF, Kimmel SE, Lee MTM, Limdi NA ...
N Engl J Med 360, 753-64, 2009
Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes
R Malik, G Chauhan, M Traylor, M Sargurupremraj, Y Okada, A Mishra, ...
Nature genetics 50 (4), 524-537, 2018
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
SA Scott, K Sangkuhl, CM Stein, JS Hulot, JL Mega, DM Roden, TE Klein, ...
Clinical Pharmacology & Therapeutics 94 (3), 317-323, 2013
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin
BF Gage, C Eby, JA Johnson, E Deych, MJ Rieder, PM Ridker, ...
Clinical Pharmacology & Therapeutics 84 (3), 326-331, 2008
A pharmacogenetic versus a clinical algorithm for warfarin dosing
SE Kimmel, B French, SE Kasner, JA Johnson, JL Anderson, BF Gage, ...
New England Journal of Medicine 369 (24), 2283-2293, 2013
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
JA Johnson, L Gong, M Whirl‐Carrillo, BF Gage, SA Scott, CM Stein, ...
Clinical Pharmacology & Therapeutics 90 (4), 625-629, 2011
CYP4F2 genetic variant alters required warfarin dose
MD Caldwell, T Awad, JA Johnson, BF Gage, M Falkowski, P Gardina, ...
Blood, The Journal of the American Society of Hematology 111 (8), 4106-4112, 2008
Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for pharmacogenetics‐guided warfarin dosing: 2017 update
JA Johnson, KE Caudle, L Gong, M Whirl‐Carrillo, CM Stein, SA Scott, ...
Clinical Pharmacology & Therapeutics 102 (3), 397-404, 2017
PHARMACOGENOMICS: The Inherited Basis for Interindividual Differences in Drug Response
WE Evans, JA Johnson
Annual review of genomics and human genetics 2 (1), 9-39, 2001
Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450–2C19 (CYP2C19) Genotype and Clopidogrel Therapy
SA Scott, K Sangkuhl, EE Gardner, CM Stein, JS Hulot, JA Johnson, ...
Clinical Pharmacology & Therapeutics 90 (2), 328-332, 2011
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
GM Cooper, JA Johnson, TY Langaee, H Feng, IB Stanaway, UI Schwarz, ...
Blood, The Journal of the American Society of Hematology 112 (4), 1022-1027, 2008
β1‐Adrenergic Receptor Polymorphisms and Antihypertensive Response to Metoprolol
JA Johnson, I Zineh, BJ Puckett, SP McGorray, HN Yarandi, DF Pauly
Clinical Pharmacology & Therapeutics 74 (1), 44-52, 2003
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups
NA Limdi, M Wadelius, L Cavallari, N Eriksson, DC Crawford, MTM Lee, ...
Blood, The Journal of the American Society of Hematology 115 (18), 3827-3834, 2010
Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements
CL Aquilante, TY Langaee, LM Lopez, HN Yarandi, JS Tromberg, ...
Clinical Pharmacology & Therapeutics 79 (4), 291-302, 2006
Impact of genetic polymorphisms of the β2‐adrenergic receptor on albuterol bronchodilator pharmacodynamics
JJ Lima, DB Thomason, MHN Mohamed, LV Eberle, TH Self, JA Johnson
Clinical Pharmacology & Therapeutics 65 (5), 519-525, 1999
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci
R Saxena, CC Elbers, Y Guo, I Peter, TR Gaunt, JL Mega, MB Lanktree, ...
The American Journal of Human Genetics 90 (3), 410-425, 2012
Pharmacogenomics: challenges and opportunities
DM Roden, RB Altman, NL Benowitz, DA Flockhart, KM Giacomini, ...
Annals of internal medicine 145 (10), 749-757, 2006
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study
MA Perera, LH Cavallari, NA Limdi, ER Gamazon, A Konkashbaev, ...
The Lancet 382 (9894), 790-796, 2013
The pharmacogenetics research network: from SNP discovery to clinical drug response
KM Giacomini, CM Brett, RB Altman, NL Benowitz, ME Dolan, ...
Clinical Pharmacology & Therapeutics 81 (3), 328-345, 2007
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci
FW Asselbergs, Y Guo, EPA Van Iperen, S Sivapalaratnam, V Tragante, ...
The American Journal of Human Genetics 91 (5), 823-838, 2012
The system can't perform the operation now. Try again later.
Articles 1–20